1.1Fibrin clot seal
A dual-lumen applicator keeps fibrinogen and thrombin solutions separate until they reach its tip. Thrombin converts fibrinogen to fibrin, which forms a clot over the opening and limits air passage.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A dual-lumen applicator keeps fibrinogen and thrombin solutions separate until they reach its tip. Thrombin converts fibrinogen to fibrin, which forms a clot over the opening and limits air passage.
Separate applicator channels deliver sodium alginate solution and calcium chloride solution to the opening. Calcium ions crosslink the alginate chains where the solutions meet, forming a gel that fills the opening.
A cannula places the compressed porous sponge in the puncture tract. Saline enters the pores and expands the sponge against the tract wall, reducing the open path for air.
A dual-barrel applicator combines a multifunctional polyethylene glycol solution bearing activated ester groups with a solution bearing multiple primary amines. The ester and amine groups react to form a covalently crosslinked gel that fills the tract.
A depth marker aligns the outlet of a side-port cannula with the plane of the pleural puncture. The outlet deposits the composition into the puncture lumen, where it gels across the opening and interrupts airflow.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
A temperature-controlled test fixture uses a silicone diaphragm to separate a pressurized air chamber from a liquid reservoir. A cannula deposits chilled poloxamer 407 solution at the reservoir-side opening of a puncture in the diaphragm. The warmed fixture gels the deposit at the opening, and a pressure sensor measures air loss from the chamber.
Sodium alginate and calcium chloride solutions replace the thermosensitive polymer formulation. A dual-lumen applicator carries the solutions separately and brings the two streams together in a short mixer at its outlet. The outlet deposits the mixture next to the tract opening, where calcium ions cross-link the alginate into a gel.
A heated test chamber holds interchangeable hydrated phantom blocks with straight, 20 mm long tracts of 1, 2, or 3 mm diameter. A syringe pump dispenses 20, 80, or 180 microliters of chilled poloxamer solution, respectively, as a cannula withdraws through each tract. The chamber holds the blocks at 37 °C during gelation, and an upstream pressure sensor records pressure decay under the same starting air pressure for each bore.
A coaxial biopsy system uses an outer introducer to maintain access after removal of the sampling needle. A sealant cannula passes through the introducer, and an adjustable depth stop places its outlet at the selected segment of the access tract. A syringe dispenses the chilled thermosensitive formulation as the cannula and introducer withdraw together, leaving a deposit that gels as it warms.
A linear-array ultrasound probe images the pleural line near the access tract, and an echogenic cannula approaches in the imaging plane. The operator tracks the cannula tip on the live image and positions the outlet next to the target on the tissue side of the pleural line. The cannula dispenses a chilled thermosensitive polymer at the selected location, where the formulation gels as it warms.
A motorized carriage retracts a delivery cannula while a linear encoder reports its position to a controller. The controller starts the syringe pump when the outlet enters the programmed tract segment and sets pump flow to the carriage speed multiplied by the specified volume per unit length. The pump stops when the outlet leaves the segment, and the deposited thermosensitive polymer gels as it warms.
An aqueous solution of a poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) triblock copolymer flows through the delivery cannula while cool. The formulation gels as it warms toward body temperature and the polymer micelles pack together.
An aqueous chitosan formulation contains beta-glycerophosphate and remains flowable while cool. Warming to body temperature promotes association between chitosan chains and forms a gel at the deposition site.
A depth stop positions the cannula outlet in the tract just before the target along the insertion path. The outlet deposits a short column of composition that gels against the tract wall and closes the air passage.
A lateral outlet deposits the composition on the pleural surface immediately beside the target puncture on the approach side. The composition gels in contact with the pleural surface and covers the adjacent opening.
patent.fyi, US 2026/0355383 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355383/, SHA-256 3b95ee001a710ad5e1c4bad45c0d2bc7c72c84a3199543b38543209bbd5faa58